Kisqali - direct healthcare professional communication (DHPC)

Ribociclib

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Kisqali (ribociclib): change to storage conditions and shelf-life

Key facts

• Medicine name:
  Kisqali
• Active substance:
  Ribociclib
• Therapeutic area (MeSH):
  Breast Neoplasms
• Procedure number:
  EMEA/H/C/004213/II/0045
• DHPC type:
  Post-authorisation measure
• Human ATC codes:
  L01EF02
• Dissemination date:
  19/02/2025